Non-coding RNA and Lung Cancer Progression.
Lung cancer (LC) is a major killer disease globally. This situation is further supported by yearly increase in new LC cases and its poor 5 years survival which is less than 15%. Although large percentage of LC cases have been attributed to smoking but considerable amount of non-smokers also develop this disease. Therefore, suggesting a genetic and/or epigenetic undertone to LC development. Several growth related genes such as EGFR and VEGF as well as tumour suppressor genes such as p53 have been implicated in LC pathogenesis and progression. In the same light, the genome only contain 1% of coding regions. Hence, non-coding portion of the genome such as non-coding RNAs have been studied and discovered to play a cogent role in LC pathogenesis. More precisely, miRNAs and lncRNAs have been studied for decade. Post-transcriptional gene modulation function of miRNAs is well established and characterized. Likewise, the antagonizing interaction between lncRNAs and miRNAs had also been proven to further control gene expression during healthy and diseases conditions like LC. More recently, renewed attention toward circRNAs study showed that circRNAs can also sponge miRNAs in order to modulate gene expressions too. Hence, miRNAs, lncRNAs and circRNAs seems to function within a circuit to optimally determine which gene is needed to be upregulated or downregulated in biological system. Therefore, this review will discuss important non-coding RNAs namely microRNA, lncRNA, circRNA in LC progression. Paracrine effect of exosomal ncRNA will be also reviewed. In addition, the prospect of these non-coding RNAs in enhancing better LC treatment will be highlighted as well.